In September, Arctic Vision worked with Dr. Nicholas Fung Siu Kay, leading clinical ophthalmologist at the University of Hong Kong Eye Center, to conduct the first-ever suprachoroidal space (SCS®) microinjection treatment for patients with macular edema uveitis. This marks the first real-world application of this groundbreaking therapy outside of the United States. The momentous milestone for Arctic Vision was covered in a report by top-tier Hong Kong media